Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    Scorr-Insert
    X

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    A collaboration with SCORR Marketing

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Foamix Pharmaceuticals

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              ISRAEL Israel

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              ASCO 2020

              Participation Not Confirmed

              Update your events

              Menlo Therapeutics and Cutia Therapeutics ink License Agreement for AMZEEQ™ and Approved Topical Minocycline Products in Greater China

              Contact the Supplier

              Lead Product(s): Minocycline

              Therapeutic Area: Dermatology

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Cutia Therapeutics

              Deal Size: $11.0 million Upfront Cash: $10.0 million

              Deal Type: Licensing Agreement April 23, 2020

              Details:

              Cutia will have an exclusive license to obtain regulatory approval and sell AMZEEQ. Foamix is to supply Cutia with the finished licensed products for clinical and commercial use.

              Foamix Pharmaceuticals

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              ISRAEL Israel

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              ASCO 2020

              Participation Not Confirmed

              Update your events

              Menlo Announces Settlement to Conclude Finacea Foam Litigation

              Contact the Supplier

              Lead Product(s): Azelaic Acid

              Therapeutic Area: Dermatology

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Leo Pharma

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Licensing Agreement April 02, 2020

              Details:

              Foamix Pharmaceuticals has entered into a settlement and license agreement to resolve the remaining pending patent litigation involving Finacea® Foam.

              PharmaCompass__DigitalAd